Malignancy mimicking bisphosphonate-associated osteonecrosis of the jaw: A case series and literature review

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Volumn 117, Issue 1, 2014, Pages 32-36

  Gander, Thomas ^a   Obwegeser, Joachim A ^a   Zemann, Wolfgang ^a   Grätz, Klaus Wilhelm ^a   Jacobsen, Christine ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

AGED; ARTICLE; BREAST TUMOR; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; JAW OSTEONECROSIS; JAW TUMOR; MALE; METASTASIS; MIDDLE AGED; MULTIPLE MYELOMA; PATHOLOGY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

AGED; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; DIPHOSPHONATES; FEMALE; HUMANS; JAW NEOPLASMS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RETROSPECTIVE STUDIES;

EID: 84890355232     PISSN: 22124403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oooo.2013.08.028     Document Type: Article

References (26)

1. J.R. Berenson, B.E. Hillner, and R.A. Kyle American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma J Clin Oncol 20 2002 3719 3736
2. B.E. Hillner, J.N. Ingle, and R.T. Chlebowski American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer J Clin Oncol 21 2003 4042 4057
3. C.H. Van Poznak, S. Temin, and G.C. Yee American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer J Clin Oncol 29 2011 1221 1227
4. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 2003 1115 1117
5. J.W. Hellstein, and C.L. Marek Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63 2005 682 689
6. C. Dannemann, K.W. Grätz, M.O. Riener, and R.A. Zwahlen Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder Bone 40 2007 828 834
7. S.L. Ruggiero, T.B. Dodson, and L.A. Assael American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws - 2009 update J Oral Maxillofac Surg 67 5 suppl 2009 2 12
8. J. Rustemeyer, and A. Bremerich Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature Clin Oral Investig 14 2010 59 64
9. O. Nicolatou-Galitis, E. Papadopoulou, and T. Sarri Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112 2011 195 202
10. R.E. Coleman Bone cancer in 2011: prevention and treatment of bone metastases Nat Rev Clin Oncol 9 2012 76 78
11. R.E. Coleman, and E.V. McCloskey Bisphosphonates in oncology Bone 49 2011 71 76
12. L. Costa, A. Lipton, and R.E. Coleman Role of bisphosphonates for the management of skeletal complications and bone pain from skeletal metastases Support Cancer Ther 3 2006 143 153
13. H. Mawardi, G. Giro, and M. Kajiya A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw J Dent Res 90 2011 1339 1345
14. C. Jacobsen, P. Metzler, J. Obwegeser, W. Zemann, and K. Grã Tz Osteopathology of the jaw associated with bone resorption inhibitors: what have we learned in the last 8 years? Swiss Med Wkly 142 2012 w13605
15. A. Bedogni, G. Saia, and M. Ragazzo Bisphosphonate-associated osteonecrosis can hide jaw metastases Bone 41 2007 942 945
16. M. Frei, M.M. Bornstein, B. Schaller, P.A. Reichart, R. Weimann, and T. Iizuka Bisphosphonate-related osteonecrosis of the jaw combined with jaw metastasis of prostate adenocarcinoma: report of a case YJOMS 68 2011 863 867
17. M. Pancholi, A. Edwards, and S. Langton Bisphosphonate induced osteochemonecrosis of the jaw mimicking a tumour Br Dent J 203 2007 87 89
18. G.A. Rodan The development and function of the skeleton and bone metastases Cancer 97 3 suppl 2003 726 732
19. M.R. Allen, and D.B. Burr The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data J Oral Maxillofac Surg 67 5 suppl 2009 61 70
20. P.P. Sedghizadeh, S.K.S. Kumar, A. Gorur, C. Schaudinn, C.F. Shuler, and J.W. Costerton Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy J Am Dent Assoc 140 2009 1259 1265
21. American Association of Oral and Maxillofacial Surgeons Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 65 2007 369 376
22. A. Hirshberg, A. Shnaiderman-Shapiro, I. Kaplan, and R. Berger Metastatic tumours to the oral cavity - pathogenesis and analysis of 673 cases Oral Oncol 44 2008 743 752
23. S.B. Woo, J.W. Hellstein, and J.R. Kalmar Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws Ann Intern Med 144 2006 753 761
24. N.J. D'Silva, D.J. Summerlin, and K.G. Cordell Metastatic tumors in the jaws: a retrospective study of 114 cases J Am Dent Assoc 137 2006 1667 1672
25. S. Chiandussi, M. Biasotto, F. Dore, F. Cavalli, M.A. Cova, and R. Di Lenarda Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws Dentomaxillofac Radiol 35 2006 236 243
26. C.A. Migliorati, J. Casiglia, J. Epstein, P.L. Jacobsen, M.A. Siegel, and S.B. Woo Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper J Am Dent Assoc 136 2005 1658 1668